Add time:08/12/2019 Source:sciencedirect.com
IntroductionThis double-blind, randomized controlled trial compared the safety and efficacy of subcutaneous EPOETIN ALFA (cas 113427-24-0)-epbx, an epoetin alfa biosimilar, with the reference product, epoetin alfa, in hemodialysis patients with end-stage kidney disease and anemia who were receiving epoetin alfa maintenance treatment.
We also recommend Trading Suppliers and Manufacturers of EPOETIN ALFA (cas 113427-24-0). Pls Click Website Link as below: cas 113427-24-0 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View